Citations Report

Articles published in Clinical Schizophrenia & Related Psychoses have been cited by esteemed scholars and scientists all around the world. Clinical Schizophrenia & Related Psychoses has got h-index 41, which means every article in Clinical Schizophrenia & Related Psychoses has got 41 average citations.

Following are the list of articles that have cited the articles published in Clinical Schizophrenia & Related Psychoses.

Miyamoto, Seiya, L. Fredrik Jarskog, and W. Wolfgang Fleischhacker. "New therapeutic approaches for treatment-resistant schizophrenia: a look to the future." Journal of psychiatric research 58 (2014): 1-6.

Hofmann, Carsten, Ludger Banken, Michael Hahn, Dennis Swearingen, Sandra Nagel, and Meret Martin-Facklam. "Evaluation of the effects of bitopertin (RG1678) on cardiac repolarization: a thorough corrected QT study in healthy male volunteers." Clinical therapeutics 34, no. 10 (2012): 2061-2071.

Mazza, Mario Gennaro, Martina Capellazzi, Sara Lucchi, Ilaria Tagliabue, Aurora Rossetti, and Massimo Clerici. "Monocyte count in schizophrenia and related disorders: A systematic review and meta-analysis." Acta neuropsychiatrica 32, no. 5 (2020): 229-236.

Mamakou, Vasiliki, Ioanna Eleftheriadou, Anastasios Tentolouris, Nikolaos Sabanis, Aikaterini Drylli, and Nikolaos Tentolouris. "Diabetogenic Effects Associated with Psychiatric Treatment." Current Pharmacology Reports 4, no. 2 (2018): 103-111.

Miyamoto, Seiya, L. Fredrik Jarskog, and W. Wolfgang Fleischhacker. "New therapeutic approaches for treatment-resistant schizophrenia: a look to the future." Journal of psychiatric research 58 (2014): 1-6.

Kantrowitz, Joshua T., Neal R. Swerdlow, Walter Dunn, and Sophia Vinogradov. "Auditory system target engagement during plasticity-based interventions in schizophrenia: a focus on modulation of N-methyl-D-aspartate–type glutamate receptor function." Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 3, no. 7 (2018): 581-590.

Bernardo, Miquel, Fernando Rico-Villademoros, Clemente García-Rizo, Rosa Rojo, and Ricardo Gómez-Huelgas. "Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies." Advances in therapy (2021): 1-22.

Sumich, Alex, Antonio Castro, Ananth PP Anilkumar, Elizabeth Zachariah, and Veena Kumari. "Neurophysiological correlates of excitement in schizophrenia." Progress in Neuro-Psychopharmacology and Biological Psychiatry 46 (2013): 132-138.

Sumich, Alex, Antonio Castro, Ananth PP Anilkumar, Elizabeth Zachariah, and Veena Kumari. "Neurophysiological correlates of excitement in schizophrenia." Progress in Neuro-Psychopharmacology and Biological Psychiatry 46 (2013): 132-138.

D’Errico, Stefano, Raffaele La Russa, Aniello Maiese, Alessandro Santurro, Matteo Scopetti, Silvia Romano, Martina Zanon, Paola Frati, and Vittorio Fineschi. "Atypical antipsychotics and oxidative cardiotoxicity: review of literature and future perspectives to prevent sudden cardiac death." Journal of Geriatric Cardiology: JGC 18, no. 8 (2021): 663.

Bergantin, Leandro Bueno. "A link among schizophrenia, diabetes, and asthma: Role of Ca2+/cAMP signaling." Brain Circulation 6, no. 3 (2020): 145.

Hirigo, Agete Tadewos, and Tesfaye Teshome. "The magnitude of undiagnosed diabetes and Hypertension among adult psychiatric patients receiving antipsychotic treatment." Diabetology & Metabolic Syndrome 12, no. 1 (2020): 1-10.

Zhang, Lei, Yong Han, Zhijun Zhao, Xiangqun Liu, Yahui Xu, Guimei Cui, Xiangyang Zhang, and Ruiling Zhang. "Beneficial effects of konjac powder on lipid profile in schizophrenia with dyslipidemia: A randomized controlled trial." Asia Pacific Journal of Clinical Nutrition 29, no. 3 (2020): 505-512.

Sumich, Alex, Antonio Castro, Ananth PP Anilkumar, Elizabeth Zachariah, and Veena Kumari. "Neurophysiological correlates of excitement in schizophrenia." Progress in Neuro-Psychopharmacology and Biological Psychiatry 46 (2013): 132-138.

Qureshi, Naseem Akhtar, Dalal Salem Al-Dossari, Sara Osama Salem, Osama A. Alkhamees, and Saud M. Alsanad. "Psychotropic medication-induced weight gain or loss looked through the lens of age and psychiatric diagnoses: A narrative review." International Neuropsychiatric Disease Journal (2018): 1-30.

Zhou, Fu-Chun, Joseph WY Lee, Qi-Hang Zhang, Zuo-Li Sun, Qijing Bo, Xiao-Xiao He, Tian Han, Min Xiong, Chaohui Li, and Chuan-Yue Wang. "Higher serum C-reactive protein levels in catatonic patients: a comparison to non-catatonic patients and healthy controls." Schizophrenia bulletin 46, no. 5 (2020): 1155-1164.

Kranaster, Laura, Carolin Hoyer, Christoph Janke, and Alexander Sartorius. "Preliminary evaluation of clinical outcome and safety of ketamine as an anesthetic for electroconvulsive therapy in schizophrenia." The World Journal of Biological Psychiatry 15, no. 3 (2014): 242-250.

Gacsályi, István, Katalin Nagy, Katalin Pallagi, György Lévay, László G. Hársing Jr, Krisztina Móricz, Szabolcs Kertész et al. "Egis-11150: a candidate antipsychotic compound with procognitive efficacy in rodents." Neuropharmacology 64 (2013): 254-263.

Egorov, Andrey I., Reagan R. Converse, Shannon M. Griffin, Jennifer N. Styles, Elizabeth Sams, Edward Hudgens, and Timothy J. Wade. "Latent Toxoplasma gondii infections are associated with elevated biomarkers of inflammation and vascular injury." BMC Infectious Diseases 21, no. 1 (2021): 1-10.

Kirkpatrick, Brian. "Understanding the physiology of schizophrenia." J Clin Psychiatry 74, no. 3 (2013): e05.